Alifax Gulf Brings Latest Microbiology Patent Instruments to UAE 
Plans to expand business to cover all GCC countries

28 Sept. 2017, Dubai, UAE:  AKAB International Investment (AKAB), the pioneer in transportation & logistics, construction and trading investment together with AliFax, one of the leading Italian companies specialized in the development, production and distribution of clinical diagnostic instrumentation, announced their joint venture and distribution agreements to launch Alifax Gulf in the UAE with expansion plans to cover all the GCC countries. 

Alifax Gulf will bring the latest microbiology patent instruments to the UAE market to include ALIBOX, MOLECULAR MOUSE, HB&L-Alfred- Sidecar, HOTBLOOD and 1 Minute identification by ATR-FTIR. The products introduced will serve the healthcare industry, clinical diagnostic centers, laboratories and medical & science universities. 

Mr. Ali Khalifa Bin Beyat, President of AKAB International Investment said: “Our unwavering commitment to quality products, international expansion and global partnerships & investments has given us a prominent position in the competitive trading community. We always strive to create value for all our stakeholders and for the communities we operate in, and we are proud to be launching Alifax Gulf in the UAE and GCC markets to introduce the latest state-of-the-art microbiology instruments that caters to a wide range of industry stakeholders.”

“Alifax is strongly oriented towards scientific research and technological innovation supported by constant investment program. We understand the market needs and promptly answers the worldwide demand. Our partnership with AKAB will help us extend our distribution reach and bring our latest clinical diagnostic instrumentation to the Middle East and fulfilling the market demands.” said Dr. Paolo Galiano, President of Alifax.

Alifax diagnostic systems and kits are developed with the main focus on the total laboratory automation requirements providing fast and reliable results, method standardization, sample traceability and easy to use protocols. Alifax efforts are focused on tailoring innovative solutions to answer the market needs and improving the clinical diagnostics workflow and the patient management.